# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines ...
Vanda Pharmaceuticals shares decline as Future Pak withdraws acquisition offer following Vanda's rejection and lack of resp...
GoPro to reduce global workforce by 4% to cut costs and improve leverage. Estimated $7.5M in costs and $2.2M in office charges ...